Pro: Methylene Blue as a Rescue Therapy for Vasoplegia After Cardiac Surgery (Q50275662)

28 February 2018

title

Pro: methylene blue as a rescue therapy for vasoplegia after cardiac surgery (English)

1 reference

28 February 2018

Pro: Methylene Blue as a Rescue Therapy for Vasoplegia After Cardiac Surgery (English)

1 reference

Crossref

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

4 December 2024

1 reference

John G T Augoustides

1 reference

28 February 2018

author name string

Hynek Riha

series ordinal

1 reference

28 February 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21684764

4 December 2024

publication date

1 August 2011

1 reference

28 February 2018

August 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21684764

full work available at URL

4 December 2024

https://api.elsevier.com/content/article/PII:S105307701100317X?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

https://api.elsevier.com/content/article/PII:S105307701100317X?httpAccept=text/plain

4 December 2024

1 reference

Crossref

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Journal of Cardiothoracic and Vascular Anesthesia

4 December 2024

published in

1 reference

28 February 2018

volume

1 reference

28 February 2018

issue

1 reference

28 February 2018

page(s)

736-738

1 reference

28 February 2018

Vasoplegic syndrome--the role of methylene blue

cites work

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Vasoplegic syndrome after off-pump coronary artery bypass surgery.

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Patterns of postoperative systemic vascular resistance in a randomized trial of conventional on-pump versus off-pump coronary artery bypass graft surgery

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Is incidence of postoperative vasoplegic syndrome different between off-pump and on-pump coronary artery bypass grafting surgery?

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Vasoplegia During Cardiac Surgery: Current Concepts and Management

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Inflammatory response to cardiopulmonary bypass

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Risk factors and outcomes for 'vasoplegia syndrome' following cardiac transplantation

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

A randomized hemodynamic comparison of intravenous amiodarone with and without Tween 80.

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Selecting a vasopressor drug for vasoplegic shock after adult cardiac surgery: a systematic literature review

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Should angiotensin converting enzyme inhibitors/angiotensin II receptor antagonists be omitted before cardiac surgery to avoid postoperative vasodilation?

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Prophylactic vasopressin in patients receiving the angiotensin-converting enzyme inhibitor ramipril undergoing coronary artery bypass graft surgery

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized study.

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Vasopressin: a review of therapeutic applications

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery.

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Is methylene blue of benefit in treating adult patients who develop catecholamine-resistant vasoplegic syndrome during cardiac surgery?

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Nitric oxide: physiology, pathophysiology, and pharmacology

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Novel actions of methylene blue

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Endogenous nitric oxide and low systemic vascular resistance after cardiopulmonary bypass

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Methylene blue administration in SIRS after cardiac operations

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Methylene blue in the therapy of vasoplegic syndrome after cardiac surgery procedure

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Methylene Blue in Anaphylactic Shock

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock?

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Methylene blue for lithium-induced refractory hypotension in off-pump coronary artery bypass graft: report of two cases.

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Vasoplegia During Cardiac Surgery: Current Concepts and Management

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Spurious pulse oximetry with intrauterine methylene blue injection.

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Adverse effects of methylene blue on the central nervous system

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Vasopressin and methylene blue: alternate therapies in vasodilatory shock

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Use of methylene blue in pheochromocytoma resection: case report

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Vasoplegic syndrome during liver transplantation.

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

Methylene blue for vasopressor-resistant vasoplegia syndrome during liver transplantation

4 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.JVCA.2011.04.005

4 December 2024

Identifiers

1 reference

28 February 2018

1 reference

28 February 2018